Molecular mechanisms of connective tissue abnormalities in the Ehlers-Danlos syndrome.
D000293:Adolescent; D000328:Adult; D002648:Child; D003094:Collagen / Q000378:metabolism; D004535:Ehlers-Danlos Syndrome / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D005260:Female; D005353:Fibronectins / Q000378:metabolism; D006801:Humans; D006900:Hydroxylation; D006901:Hydroxylysine / Q000172:deficiency; D008297:Male; D008875:Middle Aged; D010434:Pepsin A / Q000378:metabolism; D010510:Periodontal Diseases / Q000209:etiology; D011347:Procollagen / Q000378:metabolism; D008240:Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase / Q000172:deficiency; D008249:Protein-Lysine 6-Oxidase / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism; D012867:Skin / Q000032:analysis / Q000648:ultrastructure; D014960:X Chromosome
D005353:Fibronectins; D011347:Procollagen; D011509:Proteoglycans; D006901:Hydroxylysine; D003094:Collagen; D008240:Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase; D008249:Protein-Lysine 6-Oxidase; D010434:Pepsin A